SARS-CoV-2 – COVID-19 Vaccine Research Tools

AAV9 (SARS-CoV-2 Spike)

Cat. No :COV-AV-S
Vector :pAV-CMV-S
Promoter :CMV
AAV9 (SARS-CoV-2 Spike, S1 domain)

Cat. No :COV-AV-S1
Vector :pAV-CMV-S1
Promoter :CMV
Adenovirus (SARS-CoV-2 Nucleocapsid)

Cat. No :COV-AD-N
Vector :pAD-CMV-S-mCMV-copGFP
Promoter :CMV
Adenovirus (SARS-CoV-2 Spike)

Cat. No :COV-AD-S
Vector :pAD-CMV-N-mCMV-copGFP
Promoter :CMV
S-Pseudotyped IDLV lentivirus (GFP)

Cat. No :COV-LENTI-GFP
Envelope Protein :Spike protein of SARS-CoV-3
RNA Genome :eGFP
Integration Deficient :Yes
S-pseudotyped IDLV Lentivirus (Spike Protein)

Cat. No :COV-LENTI-S
Envelope Protein :Spike protein of SARS-CoV-2
RNA Genome :Spike RNA of SARS-CoV-2
Integration Deficient :Yes

Covid-19 is caused by the coronavirus, SARS-CoV-2. The Spike protein (S), a structural protein on the surface of the CoV, mediates the interaction between the SARS-CoV-2 and Human cell via ACE2. Nucleocapsid (N) is a structural protein that holds the +RNA viral genome. Both the S protein and N proteins of SARS-CoV-2 are the leading target antigens in COVID-19 vaccine developments. Vigene provides S and N proteins in adenovirus, AAV and pseudotyped lentivirus that could be valuable for COVID-19 research and vaccine developments.